We examined miR-23b expression (Affymetrix, Santa Clara, CA, USA) in CD138+ myeloma cells from 38 MM patients and 18 plasma cell leukemia patients and found it to be downregulated compared with normal PCs (Figure 2a). Here, SDC1 is linked to plasma cell leukemia.